Search research articles
Contact Us
Filters
Showing results (21-30 of 36) with videos related to
Page
of 4
Sort By:
Autoimmunity Reviews
|
October 20, 2010
Solid cancer, antiphospholipid antibodies, and venous thromboembolism
Carme Font, Laura Vidal, Gerard Espinosa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 3, 2008
A phase I study of the safety and pharmacokinetics of the combination of pertuzumab (rhuMab 2C4) and capecitabine in patients with advanced solid tumors
Joan Albanell, Clara Montagut, Eileen T Jones, et al.
Molecular Cancer Therapeutics
|
March 21, 2006
Differential cellular and molecular effects of bortezomib, a proteasome inhibitor, in human breast cancer cells
Jordi Codony-Servat, Maria A Tapia, Marta Bosch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 3, 2010
Large randomized study of thymosin alpha 1, interferon alfa, or both in combination with dacarbazine in patients with metastatic melanoma
Michele Maio, Andrzej Mackiewicz, Alessandro Testori, et al.
Plos One
|
July 30, 2011
A dual role for KRT81: a miR-SNP associated with recurrence in non-small-cell lung cancer and a novel marker of squamous cell lung carcinoma
Marc Campayo, Alfons Navarro, Nuria Viñolas, et al.
Molecular and Clinical Oncology
|
August 8, 2017
Prevalence of silent breast cancer in autopsy specimens, as studied by the disease being held by image-guided biopsies: The pilot study and literature review
Zacharoula Sidiropoulou, Ana Paula Vasconcelos, Cristiana Couceiro, et al.
Academic Forensic Pathology
|
April 24, 2023
Prevalence of Imaging Detected Silent Male Breast Cancer in Autopsy Specimens: Study of the Disease Held by Image-Guided Biopsies
Zacharoula Sidiropoulou, Ana Paula Vasconcelos, Cristiana Couceiro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 27, 2006
Interleukin 6, a nuclear factor-kappaB target, predicts resistance to docetaxel in hormone-independent prostate cancer and nuclear factor-kappaB inhibition by PS-1145 enhances docetaxel antitumor activity
Josep Domingo-Domenech, Cristina Oliva, Ana Rovira, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 8, 2010
Pharmacodynamic trial of nimotuzumab in unresectable squamous cell carcinoma of the head and neck: a SENDO Foundation study
Federico Rojo, Elías Gracias, Nadia Villena, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 6, 2007
Randomized active-controlled phase II study of denosumab efficacy and safety in patients with breast cancer-related bone metastases
Allan Lipton, Guenther G Steger, Jazmin Figueroa, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 36) with videos related to
Sort By:
Page
of 4
Autoimmunity Reviews
|
October 20, 2010
Solid cancer, antiphospholipid antibodies, and venous thromboembolism
Carme Font, Laura Vidal, Gerard Espinosa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 3, 2008
A phase I study of the safety and pharmacokinetics of the combination of pertuzumab (rhuMab 2C4) and capecitabine in patients with advanced solid tumors
Joan Albanell, Clara Montagut, Eileen T Jones, et al.
Molecular Cancer Therapeutics
|
March 21, 2006
Differential cellular and molecular effects of bortezomib, a proteasome inhibitor, in human breast cancer cells
Jordi Codony-Servat, Maria A Tapia, Marta Bosch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 3, 2010
Large randomized study of thymosin alpha 1, interferon alfa, or both in combination with dacarbazine in patients with metastatic melanoma
Michele Maio, Andrzej Mackiewicz, Alessandro Testori, et al.
Plos One
|
July 30, 2011
A dual role for KRT81: a miR-SNP associated with recurrence in non-small-cell lung cancer and a novel marker of squamous cell lung carcinoma
Marc Campayo, Alfons Navarro, Nuria Viñolas, et al.
Molecular and Clinical Oncology
|
August 8, 2017
Prevalence of silent breast cancer in autopsy specimens, as studied by the disease being held by image-guided biopsies: The pilot study and literature review
Zacharoula Sidiropoulou, Ana Paula Vasconcelos, Cristiana Couceiro, et al.
Academic Forensic Pathology
|
April 24, 2023
Prevalence of Imaging Detected Silent Male Breast Cancer in Autopsy Specimens: Study of the Disease Held by Image-Guided Biopsies
Zacharoula Sidiropoulou, Ana Paula Vasconcelos, Cristiana Couceiro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 27, 2006
Interleukin 6, a nuclear factor-kappaB target, predicts resistance to docetaxel in hormone-independent prostate cancer and nuclear factor-kappaB inhibition by PS-1145 enhances docetaxel antitumor activity
Josep Domingo-Domenech, Cristina Oliva, Ana Rovira, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 8, 2010
Pharmacodynamic trial of nimotuzumab in unresectable squamous cell carcinoma of the head and neck: a SENDO Foundation study
Federico Rojo, Elías Gracias, Nadia Villena, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 6, 2007
Randomized active-controlled phase II study of denosumab efficacy and safety in patients with breast cancer-related bone metastases
Allan Lipton, Guenther G Steger, Jazmin Figueroa, et al.
Page
of 4